Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 4,073 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Focus Groups
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 40 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Mild Alzheimer's Disease
Interventions: Non-invasive brainstem stimulation; Device
Lead sponsor: Scion NeuroStim; Industry
Eligibility: 65 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 5
States / cities: Boca Raton, Florida • Tampa, Florida • Chapel Hill, North Carolina + 2 more

Conditions: Chronic Graft-versus-host-disease
Interventions: Itacitinib, Extracorporeal Photopheresis (ECP); Drug · Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Obesity
Interventions: PILI 'Ohana 18-month weight loss maintenance; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 4
States / cities: Honolulu, Hawaii

Conditions: Spinal Cord Injuries, Spasticity, Muscle
Interventions: Electrical neuromodulation; Other
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Jackson, Mississippi

Conditions: Type 2 Diabetes Mellitus
Interventions: GlucoType; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 2
States / cities: New York, New York

Conditions: Overactive Bladder, Urge Urinary Incontinence
Interventions: PTNS (Percutaneous Tibial Nerve Stimulation, TENS (Transcutaneous Electrical Nerve Stimulation); Device
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 3
States / cities: Bethesda, Maryland • Fort Belvoir, Virginia • Portsmouth, Virginia

Conditions: Tourette Syndrome, Tic Disorder, Chronic Motor or Vocal
Interventions: Active, self-directed electrical stimulation of the median nerve; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 65 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pain, Pain Management
Interventions: NRS pain one week, PEG, DVPRS; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 569 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Palo Alto, California • Minneapolis, Minnesota • Portland, Oregon

Conditions: Smoking Cessation, Acute Coronary Syndrome
Interventions: Behavioral Activation (BA), Standard Smoking Cessation Counseling, Nicotine patch, Printed Self-help materials for Smoking Cessation; Behavioral · Drug · Other
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Opioid Use, Pain, Marijuana Use
Interventions: Cannabis, Prescription Opioid Taper Support (POTS); Drug · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Portland, Maine • Boston, Massachusetts • Cambridge, Massachusetts

Conditions: Resuscitation of Newborn Training
Interventions: Self instructed video learning, instructor training; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 70 Years
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: New York, New York • Oklahoma City, Oklahoma

Conditions: Mental Illness, Chronic Medical Illness
Interventions: Living Well, Medical Illness Education & Support Group; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Environment Related Disease
Interventions: Go NAP SACC; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Diabetes Mellitus, Type 1
Interventions: Resilient, Empowered, Active Living-Telehealth (REAL-T); Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 30 Years
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression
Interventions: Action Brings Change Project (15-minute adult version), Action Brings Change Project (10-minute adult version), Action Brings Change Project (6-minute adult version), Action Brings Change Project (2-minute adult version); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 1,145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Non Small Cell Lung Cancer
Interventions: Entinostat, Erlotinib; Drug
Lead sponsor: Syndax Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 5
States / cities: San Diego, California • Miami, Florida • Chicago, Illinois + 2 more

Conditions: Obesity
Interventions: Food Craving app, Sleep Coach app; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: SARS-CoV-2 Infection, Influenza A, Influenza B
Interventions: Aptitude Medical Systems Metrix COVID/Flu Test; Diagnostic Test
Lead sponsor: Aptitude Medical Systems; Industry
Eligibility: 2 Years and older
Enrollment: 614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Trussville, Alabama • Goleta, California • Chelmsford, Massachusetts

Conditions: Castration-resistant Prostate Cancer
Interventions: BEZ235, BKM120; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Los Angeles, California • Hackensack, New Jersey

Conditions: Post-Traumatic Stress Disorders, Opiate Use Disorder
Interventions: Buprenorphine, Cognitive Processing Therapy (CPT), Individual Drug Counseling (IDC); Drug · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: West Haven, Connecticut • Bedford, Massachusetts

Conditions: Alcohol Dependence, Anxiety
Interventions: Doxazosin, Placebo; Drug
Lead sponsor: Brown University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Providence, Rhode Island

Conditions: Cancer
Interventions: Pre-Test Intervention, Standard of Care, Post-Test Intervention; Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cervical Cancer, HPV Infection
Interventions: Qualitative Interview, Virtual Visit Standard Instructions, Virtual Visit Standard Instructions + In-Person Registration Navigation; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 25 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Study Of PHarmacogenetics in Ethnically Diverse Populations (SOPHIE Study)

WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease

Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD

Partnerships to Overcome Obesity Disparities in Hawaii: 18-month CBPR Study

Transcutaneous Spinal Stimulation for Lower Limb Spasticity in Spinal Cord Injury

Personalizing Self-management in Diabetes - Pilot Study

Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments

Open-label MNS for Tourette Syndrome

Effective Screening for Pain Study

Post Acute Coronary Event Smoking Study

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Self-directed Video Versus Instructor-based Neonatal Resuscitation Training

Wellness Self-Management

A Pilot Study Evaluating Go NAP SACC's Web-based Nutrition Tool for Child Care

Evaluation of an Intervention for Young Adults With Diabetes: Resilient, Empowered, Active Living-Telehealth (REAL-T)

What SSI Duration is Most Effective? An Online Experiment With American Adults

A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib

The Sleep and Weight Study

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients

Optimal Treatment of Veterans With PTSD and Comorbid OUD

Doxazosin an a1 Antagonist for Alcohol Dependence

Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening